We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+0.84%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$9.62B
AUM Growth
+$9.12B
Cap. Flow
+$10.4B
Cap. Flow %
107.78%
Top 10 Hldgs %
35.81%
Holding
968
New
940
Increased
2
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
ROG icon
Rogers Corp
ROG
+$473M
2
ACC
American Campus Communities, Inc.
ACC
+$454M
3
CTXS
Citrix Systems Inc
CTXS
+$421M
4
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
+$312M
5
CDK
CDK Global, Inc.
CDK
+$286M

Top Sells

Rank Stock Value
1
TGNA
TEGNA Inc
TGNA
+$1.1M

Sector Composition

Rank Sector Weight
1 Technology 27.77%
2 Financials 20.93%
3 Industrials 11.05%
4 Healthcare 9.88%
5 Communication Services 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PATH icon
651
UiPath
PATH
$7.25B
$1.82M 0.02%
+100,000
New +$1.87M
BBBY
652
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
$1.81M 0.02%
+234,200
New +$2.73M
HHLA
653
DELISTED
HH&L Acquisition Co.
HHLA
$1.81M 0.02%
+184,388
New +$1.81M
HORI
654
DELISTED
Emerging Markets Horizon Corp. Class A Ordinary Shares
HORI
$1.78M 0.02%
+180,162
New +$1.78M
BRIV
655
DELISTED
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
$1.77M 0.02%
+181,701
New +$1.77M
DY icon
656
Dycom Industries
DY
$12B
$1.76M 0.02%
+18,955
New +$1.69M
PTGX icon
657
Protagonist Therapeutics
PTGX
$9.46B
$1.74M 0.02%
+219,820
New +$2.66M
SKYA
658
DELISTED
Skydeck Acquisition Corp. Class A Ordinary Shares
SKYA
$1.74M 0.02%
+178,196
New +$1.74M
NRG icon
659
NRG Energy
NRG
$25B
$1.73M 0.02%
+45,323
New +$1.85M
ADPT icon
660
Adaptive Biotechnologies
ADPT
$3.75B
$1.73M 0.02%
+213,490
New +$1.88M
ENDP
661
PUT
DELISTED
Endo International plc
ENDP
$1.71M 0.02%
+447,500
New +$568K
CORS
662
DELISTED
Corsair Partnering Corporation
CORS
$1.71M 0.02%
+176,344
New +$1.72M
VSTM icon
663
Verastem
VSTM
$519M
$1.66M 0.02%
+118,915
New +$1.89M
AUTL
664
Autolus Therapeutics
AUTL
$532M
$1.65M 0.02%
+584,246
New +$1.78M
O icon
665
Realty Income
O
$59B
$1.65M 0.02%
+24,121
New +$1.66M
ANAB icon
666
AnaptysBio
ANAB
$1.62B
$1.64M 0.02%
+80,966
New +$1.79M
MRUS
667
DELISTED
Merus
MRUS
$1.63M 0.02%
+72,116
New +$1.51M
CRNX icon
668
Crinetics Pharmaceuticals
CRNX
$8.9B
$1.63M 0.02%
+87,460
New +$1.75M
ORIC icon
669
Oric Pharmaceuticals
ORIC
$1.34B
$1.62M 0.02%
+361,055
New +$1.44M
VRTX icon
670
Vertex Pharmaceuticals
VRTX
$123B
$1.6M 0.02%
+5,690
New +$1.52M
ESTA icon
671
Establishment Labs
ESTA
$2.33B
$1.6M 0.02%
+29,426
New +$1.87M
REVE
672
DELISTED
Alpine Acquisition Corp
REVE
$1.6M 0.02%
+157,507
New +$1.6M
RIG icon
673
PUT
Transocean
RIG
$5.71B
$1.59M 0.02%
+1,967,700
New +$7.97M
KROS icon
674
Keros Therapeutics
KROS
$211M
$1.58M 0.02%
+57,321
New +$2.52M
ACRS icon
675
Aclaris Therapeutics
ACRS
$851M
$1.58M 0.02%
+113,426
New +$1.59M
25 26
27
28 29

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q2 2022 Portfolio in Review

As of Q2 2022, UBS O'Connor held 968 positions worth $9.62B, up 1,838% from $496M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

UBS O'Connor deployed $10.4B of net new capital in Q2 2022, opening 940 new positions and adding to 2 existing holdings. Its largest new stake was Rogers Corp: 1,780,443 shares worth $467M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 85% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was TEGNA Inc, an estimated $1.1M trimmed.

  • UBS O'Connor's largest Q2 2022 buy was Rogers Corp: 1,780,443 shares worth $467M.
  • UBS O'Connor added most to Activision Blizzard in Q2 2022, an estimated $107M increase.
  • UBS O'Connor's biggest Q2 2022 reduction was TEGNA Inc, cutting an estimated $1.1M.
  • UBS O'Connor's ten largest holdings make up 36% of its $9.62B portfolio in Q2 2022.
  • UBS O'Connor opened 940 new positions and closed 0 in Q2 2022.
  • UBS O'Connor's portfolio value rose 1,838% quarter-over-quarter to $9.62B.

Based on UBS O'Connor's 13F filing for Q2 2022, filed 12 Aug 2022.